Trademark: 90363450
Status Date
Monday, February 19, 2024
Filing Date
Monday, December 7, 2020
Published for Opposition
Tuesday, July 6, 2021
42 Providing a bioinformatics platform as a service (PAAS) featuring computer software for sequence data analysis in the field of manufacturing therapeutics; Software as a service (SaaS) services featuring software for assisting in the diagnosis of medical conditions in relation to advanced therapy and cell therapy medications; Cloud computing featuring software for use in assisting in the diagnosis of medical conditions; Providing search engines for the internet in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Computer services, namely, the creation for registered users of virtual communities allowing the organization of groups and events, the participation to discussion, and the involvement into the social, business and community networking in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Computer services, namely, electronic hosting of online web facilities for the organization by third parties of colloquiums, events and interactive discussions, via communication networks in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Hosting digital content for users account in the Internet in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Designing online forums in the field of manufacture of advanced therapy and cell; Software as a service (SAAS) services, namely, hosting software for use by others for managing supply chains and logistics, tracking and delivering custom cell and gene therapies; software as a service (SAAS) services, namely, hosting software for use by others for managing cold chain and vein-to-vein supply chains and logistics, tracking and delivering custom cell and gene therapies; software as a service (SAAS) services featuring non-downloadable software for ordering, tracking, scheduling, production, manufacturing, business intelligence, and delivery of custom cell and gene therapies; software as a service (SaaS) services featuring software for the processing, separation, isolation, enrichment, depletion, cell activation, genetic modification, detection, screening, analysis and counting of material
The mark consists of a circular ring with two breaks on the right side and surrounded by 8 evenly spaced and outwardly facing semicircles.
Feb 20, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 19, 2024
Sou Extension 5 Granted
Feb 19, 2024
Sou Extension 5 Filed
Feb 19, 2024
Sou Teas Extension Received
Jul 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 14, 2023
Sou Extension 4 Granted
Jul 14, 2023
Sou Extension 4 Filed
Jul 14, 2023
Sou Teas Extension Received
Jan 27, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 25, 2023
Sou Extension 3 Granted
Jan 25, 2023
Sou Extension 3 Filed
Jan 25, 2023
Sou Teas Extension Received
Jul 28, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 26, 2022
Sou Extension 2 Granted
Jul 26, 2022
Sou Extension 2 Filed
Jul 26, 2022
Sou Teas Extension Received
Feb 12, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 12, 2022
Corrected Noa E-Mailed
Feb 11, 2022
Divisional Processing Complete
Jan 31, 2022
Divisional Request Received
Feb 11, 2022
Sou Extension 1 Granted
Jan 29, 2022
Sou Extension 1 Filed
Feb 11, 2022
Case Assigned To Intent To Use Paralegal
Feb 7, 2022
Teas Change Of Correspondence Received
Feb 7, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 7, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 31, 2022
Teas Request To Divide Received
Jan 29, 2022
Sou Teas Extension Received
Aug 31, 2021
Noa E-Mailed - Sou Required From Applicant
Jul 6, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 6, 2021
Published For Opposition
Jun 16, 2021
Notification Of Notice Of Publication E-Mailed
May 29, 2021
Approved For Pub - Principal Register
May 29, 2021
Examiner's Amendment Entered
May 29, 2021
Notification Of Examiners Amendment E-Mailed
May 29, 2021
Examiners Amendment E-Mailed
May 29, 2021
Examiners Amendment -Written
May 26, 2021
Assigned To Examiner
Feb 12, 2021
Notice Of Design Search Code E-Mailed
Feb 11, 2021
New Application Office Supplied Data Entered
Dec 10, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
